3/1/2018

Promethazine Injection

Products Affected - Description

- Promethazine injection, Pfizer, 25 mg/mL, 1 mL Carpuject syringe, 10 count, NDC 00409-2312-31
- Promethazine injection, Teva, 25 mg/mL, 1 mL vial, 25 count, NDC 00703-2191-04
- Promethazine injection, Teva, 50 mg/mL, 1 mL vial, 25 count, NDC 00703-2201-04

Reason for the Shortage

- Teva is not marketing promethazine injection at this time.
- West-Ward has promethazine available.
- Hospira discontinued promethazine in 2016.
- X-Gen has promethazine available.

Available Products

- Phenergan injection, West-Ward, 25 mg/mL, 1 mL ampule, 25 count, NDC 00641-6082-25
- Phenergan injection, West-Ward, 25 mg/mL, 1 mL vial, 25 count, NDC 00641-6084-25
- Phenergan injection, West-Ward, 50 mg/mL, 1 mL ampule, 25 count, NDC 00641-6083-25
- Phenergan injection, West-Ward, 50 mg/mL, 1 mL vial, 25 count, NDC 00641-6085-25
- Promethazine injection, West-Ward, 25 mg/mL, 1 mL ampule, 25 count, NDC 00641-1495-35
- Promethazine injection, West-Ward, 25 mg/mL, 1 mL vial, 25 count, NDC 00641-0928-25
- Promethazine injection, West-Ward, 50 mg/mL, 1 mL ampule, 25 count, NDC 00641-1496-35
- Promethazine injection, West-Ward, 50 mg/mL, 1 mL vial, 25 count, NDC 00641-0929-25
- Promethazine injection, X-Gen, 25 mg/mL, 1 mL ampule, 25 count, NDC 39822-5525-03
- Promethazine injection, X-Gen, 50 mg/mL, 1 mL ampule, 25 count, NDC 39822-5550-06

Estimated Resupply Dates

- All marketed presentations are available.

Updated

Updated March 1, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created June 22, 2010 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.